Name: 글로벌 시장 동향
SKU: BT2681
Availability: InStock

보고서 요약(국문)

시장 개요
바이오프로세스 검증은 특정 공정이 미리 정해진 사양과 품질 특성을 충족하는 제품을 일관되게 생산한다는 것을 보장하기 위해 문서 증거를 수집하는 과정입니다. 바이오프로세스 검증의 중요한 부분은 동물 소독제 또는 기타 생물학적 제품의 개발 및 제조 과정에서 활성 의약품 성분(API)과 마이코플라스마, 박테리아, 엔도톡신 등의 오염 물질을 평가하는 것입니다.
글로벌 바이오프로세스 검증 시장은 2022년 2,246억 8,730만 달러 규모였으며, 2030년까지 연평균 11.20%의 성장률을 보일 것으로 예상됩니다.
시장 동향
바이오의약품에 대한 전 세계적인 수요 증가가 바이오프로세스 검증 시장의 수요를 촉진할 것으로 예상됩니다.
바이오의약품에 대한 막대한 수요는 연구 개발 관련 투자의 가속화에 힘입어 더욱 증가하고 있습니다. 바이오프로세스 검증 서비스 아웃소싱에 대한 높은 수요, 제약 및 바이오의약품 산업을 넘어 헬스케어 산업 전반에 걸쳐 제품 인증 및 테스트를 규제하는 엄격한 안전 및 품질 규정, 그리고 우수 제조 기준(GMP) 준수 요구는 전 세계 바이오프로세스 검증 산업 성장을 견인하는 주요 요인입니다.
단, 추출물 및 용출물 관련 문제는 전 세계 바이오프로세스 검증 시장 성장을 저해할 것으로 예상됩니다.
최근 바이오프로세스 개발 및 바이오의약품 제조 분야에서 일회용 기술이 널리 채택되고 있습니다. 이러한 기술의 이점은 잘 알려져 있지만, 일회용 시스템 구성 요소에서 발생하는 추출물 및 용출물이 제품 품질과 환자 건강에 미칠 수 있는 잠재적 영향에 대한 우려가 존재합니다. 추출물 및 용출물이 제품으로 유입될 가능성과 환자에게 미칠 수 있는 잠재적 위험을 평가하기 위해서는 일반적으로 위험 평가가 필요합니다. 예측 기간 동안 추출물 및 용출물 관련 문제는 전 세계 바이오프로세스 검증 시장 성장을 저해할 것으로 예상됩니다.

신흥 시장으로의 확장은 글로벌 바이오프로세스 검증 시장에 새로운 기회를 창출할 것으로 예상됩니다.
아시아 지역에서는 중국이 바이오프로세스 검증 시장의 잠재력이 가장 높은 시장이며, 그 뒤를 인도가 잇고 있습니다. 이러한 시장의 성장은 정부의 우호적인 지원, 민간 투자 증가, 고령 인구 증가, 그리고 아시아 신흥 국가로의 아웃소싱 증가 추세에 기인합니다. 인도, 일본, 브라질은 시장 참여자들에게 새로운 수익 창출의 기회가 될 것으로 예상됩니다. 또한, 바이오 제조 인프라에 대한 높은 투자는 이러한 시장의 높은 성장 잠재력을 뒷받침하는 주요 요인입니다. 신흥 시장이 제공하는 새로운 기회는 글로벌 시장의 성장을 촉진할 것으로 기대됩니다.
그러나 바이오프로세스 검증에 대한 엄격한 정부 규제는 글로벌 바이오프로세스 검증 시장에 어려움을 초래할 것으로 예상됩니다.
검증은 제약 및 생명공학 기업이 대중에게 안전한 의약품을 일관되게 생산하고 있음을 입증하기 위한 규제 요건입니다. 기업은 규제 기관의 감사 등 요청 시 검증 활동에 대한 증거를 제시할 수 있어야 합니다. 생물공정 검증에 대한 정부 규정의 복잡성으로 인해 더 넓은 범위의 응용 분야에서 검증이 도입되지 못하고 있으며, 이는 전 세계 생물공정 검증 시장의 성장에 걸림돌이 되고 있습니다.
시장 세분화:
본 보고서는 시험 유형, 공정 구성 요소, 최종 사용자 및 지역별 시장 세분화를 다룹니다. 전 세계 생물공정 검증 시장은 시험 유형별로 추출물/용출물 시험 서비스, 미생물 시험 서비스, 무결성 시험 서비스, 물리화학적 시험 서비스, 호환성 시험 서비스 및 기타로 세분화됩니다. 공정 구성 요소별로는 배지 용기 및 백, 동결 및 해동 공정 백, 필터 요소, 생물반응기 및 기타로 세분화됩니다. 최종 사용자별로는 제약 회사, 생명공학 회사, 위탁 개발 및 제조 조직(CDMO) 및 기타로 세분화됩니다. 지역별로는 북미, 남미, 유럽, 아시아 태평양, 중동 및 아프리카로 세분화됩니다.

제약 회사: 제약 회사는 최종 사용자 부문에서 큰 비중을 차지하고 있는데, 이는 생물약품 생산량 증가와 그에 따른 불순물 검사 필요성 증가, 그리고 생산에 관련된 생물공정의 품질 및 유효성에 대한 엄격한 기준과 규정 때문입니다.
생명공학 회사: 생명공학 분야는 정부의 우호적인 정책 덕분에 빠르게 성장하고 있습니다. 정부는 의약품 규제 경로 현대화, 임상 연구 표준화, 상환 정책 개선, 제품 승인 절차 신속화 등을 통해 시장에 수익성 있는 성장 기회를 제공하고 있습니다.
위탁 개발 및 제조 조직(CDMO): 제약 산업의 발전과 함께, 주요 위탁 개발 및 제조 조직(CDMO)들은 역량 격차를 해소하기 위해 노력하고 있습니다. 다양한 서비스를 제공하는 CDMO는 제약 회사들이 단일 업체와만 거래하면 되므로 편의성, 시간 절약, 비용 효율성을 높여줍니다. 이러한 관계는 CDMO가 동일한 고객에게 더 많은 서비스를 판매하고 제품 수명 주기의 초기 단계에서 제품을 확보할 수 있는 기회를 창출합니다.
기타: 이 부문은 주로 실험실 및 연구 기관을 포함합니다. 완충액 성분, 항생제, 계면활성제, 소포제, 공정 개선제, 촉매 또는 접촉 재료에서 용출되는 화합물과 같은 공정 관련 세포 유래 불순물은 연구 프로젝트를 방해할 수 있습니다. 따라서 공정 검증 연구에는 광범위한 테스트 기능과 전문 지식이 필요합니다.
지역 분류:
DataM Intelligence 시장 조사 보고서에 따르면 글로벌 바이오 공정 검증 시장은 다음과 같이 구분됩니다.
...지역 분류:
DataM Intelligence 시장 조사 보고서에 따르면 글로벌 바이오 공정 검증 시장은 다음과 같이 구분됩니다. 북미 - 미국 및 캐나다
남미 - 브라질, 아르헨티나, 페루, 칠레 및 기타 남미 국가
유럽 - 영국, 독일, 이탈리아, 프랑스, 스페인, 러시아 및 기타 유럽 국가
아시아 태평양 - 중국, 인도, 일본, 한국, 싱가포르, 호주, 말레이시아 및 기타 아시아 태평양 국가
중동 및 아프리카 - UAE, 사우디아라비아, 카타르, 남아프리카공화국 및 기타 중동 국가
경쟁 환경:
글로벌 바이오프로세스 검증 시장은 여러 국제 및 지역 업체들이 경쟁하는 비교적 경쟁적인 시장입니다. 주요 업체들은 라이선스 활동, 협력, 인수합병, 정부와의 제휴, 합작 투자 등 다양한 성장 전략을 채택하여 글로벌 바이오프로세스 검증 시장의 성장에 기여하고 있습니다.

주요 기업:
글로벌 바이오프로세스 검증 시장 성장에 기여하는 주요 기업으로는 Cobetter Filtration Equipments Co., Ltd., SGS S.A., DOC S.r.l., Thermo Fisher Scientific, Sartorius Stedim Biotech, Merck KGaA, Meissner Filtration Products, Inc., Eurofins Scientific, Boston Analytical, Danaher Corporation(Pall Corporation) 등이 있습니다.
업계 최근 동향:
2022년 7월, 백신 제조업체인 Vaccizone은 생명공학 연구 회사인 Exothera와 파트너십을 체결하여 Exothera의 Scale-X 기술을 활용해 신속한 바이오프로세스 검증을 통해 Vaccizone의 COVID-19 백신을 개발한다고 발표했습니다.
2022년 6월, Alder Therapeutics는 스웨덴 생명공학 회사인 NorthX Biologics의 바이오프로세스 검증을 지원하는 계약을 발표했습니다. 이 계약을 통해 NorthX Biologics는 만능 줄기세포 연구 분야로 사업을 확장할 수 있게 됩니다.

2022년 6월, 제퍼슨 생물공정 연구소(JIB)는 미국 필라델피아에 위치한 버드 바이오웍스 연구 공간에서 생물기술자 교육 및 검증 프로그램을 시작한다고 발표했습니다.
COVID-19 영향 분석
COVID-19는 시장에 상당한 영향을 미쳤습니다. 팬데믹으로 인해 전 세계적으로 다양한 예방적 봉쇄 조치 및 기타 정부 제한으로 제조 및 공급망 운영에 상당한 차질이 발생했습니다. 정확성, 효율성 및 안전성을 모니터링하기 위해 의약품 개발의 모든 단계에서 검증이 필요하기 때문에 팬데믹 기간 동안 생물공정 검증에 대한 수요가 증가했습니다. 팬데믹은 생물공정 검증에 대한 수요를 증가시켰으며, 이는 생물공정 검증 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.

보고서 요약(영어 원문)

Market Overview
Bioprocess Validation is a process that involves collecting documentary evidence to ensure that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes. An important part of bioprocess validation requires evaluating active pharmaceutical ingredients (APIs) and possible contaminants, such as mycoplasma, bacteria, endotoxin, and others, during the development and manufacture processes of animal disinfectants or other biological products.
The Global Bioprocess Validation Market was valued at USD 224,687.30 million in 2022. It is forecasted to reach USD YY million by 2030, growing at a CAGR of 11.20% during the forecast period (2023-2030).
Market Dynamics
Increasing global demand for biopharmaceuticals is expected to boost the demand for the bioprocess validation market
The huge demand for biopharmaceuticals is facilitated by an accelerating focus on research and development-related investments. High demand for outsourcing bioprocess validation services, stringent safety and quality regulations governing product certifications and testing beyond the biopharmaceutical and pharmaceutical industries in the healthcare industry to maintain the agreement with good manufacturing practices are the important factors propelling the growth of the global bioprocess validation industry.
Issues related to extractables and leachables are expected to restrain the global bioprocess validation market
Single-use technology has been adopted widely in bioprocess development and biopharmaceutical manufacturing in recent years. While the benefits of such technologies are well recognized, there are significant concerns regarding extractable and leachable from the components of single-use systems owing to their potential effect on product quality and patient health. A risk assessment is normally required to assess the probability of extractable and leachables migrating into the product stream and their potential risk to the patient. During the forecast period, the issues related to extractables and leachables are expected to restrain the growth of the global market for bioprocess validation.
Expansion into emerging markets is expected to generate new opportunities for the global bioprocess validation market
In the Asian region, China is a high-potential market for bioprocess validation, followed by India. The growth in this market can be attributed to favorable government support, rising private investments, a growing geriatric population, and a rising trend of outsourcing to emerging Asian countries. India, Japan, and Brazil are expected to be the new revenue pockets for market players. Also, the high investment in bio-manufacturing infrastructure is a key factor responsible for the high-growth potential of these markets. The new opportunities offered by the emerging markets are expected to boost the growth of the global market.
Stringent government regulations on bioprocess validation are expected to present challenges for the global market for bioprocess validation
Validation is a regulatory requirement for pharmaceutical and biotechnology companies to confirm that they consistently manufacture safe medicines for the public. Companies must be able to provide proof of validation activities when requested, such as during an audit by regulatory agencies. The complexity of government regulations for bioprocess validation prevents its adoption for a wider range of applications and presents a challenge to the growth of the global bioprocess validation market.
Market Segmentation:
The scope of the report covers segmentation based on test type, process component, end-user and region. The global bioprocess validation market is segmented by test type into extractables/leachables testing services, microbiological testing services, integrity testing services, physiochemical testing services, compatibility testing services and others. The global market is segmented by process component into media containers and bags, freezing and thawing process bags, filter elements, bioreactors and others. The global market is segmented by end-user into pharmaceutical companies, biotechnology companies, contract development and manufacturing organizations and others. The global market is segmented by region into North America, South America, Europe, Asia-Pacific, Middle East and Africa.
Pharmaceutical Companies: Pharmaceutical companies have a large share of the end-user segment, which can majorly be attributed to the increasing production of biopharmaceuticals and the corresponding increase in the number of impurities to be checked for, the stringency of standards and regulations regarding the quality and validity of bioprocesses involved in the production
Biotechnology Companies: The biotechnology sector is experiencing rapid growth due to favorable governmental policies. Government initiatives are oriented towards modernizing the drug regulatory pathway, standardizing clinical studies, improving reimbursement policies, and speeding up the product approval process, thereby offering lucrative growth opportunities to the market.
Contract Development & Manufacturing Organizations: With developments in the pharmaceutical industry, leading contract development and manufacturing organizations (CDMOs) aim to seek and bridge capability gaps. CDMOs offering multiple services increase convenience, save time, and enhance cost efficiency as pharmaceutical companies have to only deal with a single entity. The relationship also creates opportunities for the CDMOs to sell more services to the same customer and lock in products at earlier stages of their life cycles
Others: The segment mainly includes laboratories and research institutes. Process-related cell-derived impurities such as buffer components, antibiotics, surfactants, anti-foaming agents, process enhancing agents, catalysts, or compounds that leach from contact materials can impede research projects. Therefore, process validation studies require a broad set of testing capabilities and expertise.
Regional Classification:
According to the DataM Intelligence market research report, the global bioprocess validation market is divided into;
North America - United States, and Canada
South America - Brazil, Argentina, Peru, Chile, and Rest of the South American countries
Europe - UK, Germany, Italy, France, Spain, Russia, and the rest of the European countries
Asia-Pacific - China, India, Japan, South Korea, Singapore, Australia, Malaysia, and the Rest of the Asia Pacific countries
Middle East and Africa - UAE, KSA, Qatar, South African Countries, and the Rest of the Middle East countries
Competitive Landscape:
The global bioprocess validation market is moderately competitive with several international and regional players. The major players adopt several growth strategies such as licensing activities, collaborations, mergers and acquisitions, government tie-ups, and joint ventures, thereby contributing to the growth of the global bioprocess validation market.
Major Companies:
Some key companies contributing to the growth of the global bioprocess validation market include Cobetter Filtration Equipments Co., Ltd., SGS S.A., DOC S.r.l., Thermo Fisher Scientific, Sartorius Stedim Biotech, Merck KGaA, Meissner Filtration Products, Inc., Eurofins Scientific, Boston Analytical and Danaher Corporation (Pall Corporation), among others.
Recent Developments in the Industry:
In July 2022, Vaccizone, a vaccine manufacturer, announced a partnership with Exothera, a biotechnology research company, to use Exothera's scale-X technology to develop Vaccizone's COVID-19 vaccine with expedited bioprocess validation.
In June 2022, Alder Therapeutics announced a deal to help with the bioprocess validation for NorthX Biologics, a Swedish biotech company. The deal will enable NorthX Biologics to expand into pluripotent stem cell research.
In June 2022, the Jefferson Institute for Bioprocessing (JIB) announced the commencement of its bio technician training and validation program at the Budd Bioworks research space in Philadelphia, U.S.
COVID-19 Impact Analysis
COVID-19 had a significant impact on the market. The pandemic caused significant manufacturing and supply-chain operations disruptions due to various precautionary lockdowns and other governmental restrictions globally. Because validation is required at all stages of drug development to monitor accuracy, efficiency, and safety, demand for bioprocess validation increased during the pandemic. The pandemic has increased the demand for bioprocess validation and is expected to positively impact the bioprocess validation market growth.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Test Type
3.2. Market Snippet by Process
3.3. Market Snippet by End-User
3.4. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.2. Drivers
4.2.1. Feasibility of operations and processes
4.2.2. The stringent safety and quality regulations governing product certification and testing across the biopharmaceutical and pharmaceutical industries
4.3. Restraints
4.3.1. Government regulation
4.4. Impact Analysis
4.5. Opportunity
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Pricing Analysis
5.5. Product Analysis
5.6. COVID-19 Impact Analysis
6. By Test Type
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
6.1.2. Market Attractiveness Index, By Test Type
6.2. Extractables/Leachables Testing Services *
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
6.3. Microbiological Testing Services
6.4. Integrity Testing Services
6.5. Physiochemical Testing Services
6.6. Compatibility Testing Services
6.7. Others
7. By Process
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Process
7.1.2. Market Attractiveness Index, By Process
7.2. Media containers and bags
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
7.3. Freezing and thawing process bags
7.4. Filter elements
7.5. Others
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Pharmaceutical Companies
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
8.3. Biotechnology Companies
8.4. Others
9. By Region
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.3. Market Attractiveness Index, By Region
9.4. North America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Process
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. The U.S.
9.4.6.2. Canada
9.4.6.3. Mexico
9.5. Europe
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Process
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. Germany
9.5.6.2. The U.K.
9.5.6.3. France
9.5.6.4. Rest of Europe
9.6. South America
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Process
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.6.6.1. Brazil
9.6.6.2. Argentina
9.6.6.3. Rest of South America
9.7. Asia Pacific
9.7.1. Introduction
9.7.2. Key Region-Specific Dynamics
9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Process
9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.7.6.1. China
9.7.6.2. India
9.7.6.3. Japan
9.7.6.4. Australia
9.7.6.5. Rest of Asia Pacific
9.8. Middle East and Africa
9.8.1. Introduction
9.8.2. Key Region-Specific Dynamics
9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Process
9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Cobetter Filtration Equipments Co., Ltd.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Developments
11.1.4. Financial Overview
11.2. SGS S.A.
11.3. DOC S.r.l.
11.4. Thermo Fisher Scientific
11.5. Toxikon Corporation
11.6. Sartorius Stedim Biotech
11.7. Eurofins Scientific
11.8. Pall Corporation
11.9. MEISSNER FILTRATION PRODUCTS, INC.
11.10. Merck KGaA (*List is not exhaustive)
12. DataM Intelligence
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us

언급된 주요 기업들

Cobetter Filtration Equipments Co., Ltd., 3.	Key Developments, SGS S.A., DOC S.r.l., Thermo Fisher Scientific, Toxikon Corporation, Sartorius Stedim Biotech, Eurofins Scientific, Pall Corporation, MEISSNER FILTRATION PRODUCTS, INC.

표 목록 (Tables)

List of Tables

Table 01 Global Bioprocess Validation Market Value, By Test Type, 2023, 2027 & 2031 (USD Million)

Table 02 Global Bioprocess Validation Market Value, By Process, 2023, 2027 & 2031 (USD Million)

Table 03 Global Bioprocess Validation Market Value, By End-User, 2023, 2027 & 2031 (USD Million)

Table 04 Global Bioprocess Validation Market Value, By Region, 2023, 2027 & 2031 (USD Million)

Table 05 Global Bioprocess Validation Market Value, By Test Type, 2023, 2027 & 2031 (USD Million)

Table 06 Global Bioprocess Validation Market Value, By Test Type, 2022-2031 (USD Million)

Table 07 Global Bioprocess Validation Market Value, By Process, 2023, 2027 & 2031 (USD Million)

Table 08 Global Bioprocess Validation Market Value, By Process, 2022-2031 (USD Million)

Table 09 Global Bioprocess Validation Market Value, By End-User, 2023, 2027 & 2031 (USD Million)

Table 10 Global Bioprocess Validation Market Value, By End-User, 2022-2031 (USD Million)

Table 11 Global Bioprocess Validation Market Value, By Region, 2023, 2027 & 2031 (USD Million)

Table 12 Global Bioprocess Validation Market Value, By Region, 2022-2031 (USD Million)

Table 13 North America Bioprocess Validation Market Value, By Test Type, 2022-2031 (USD Million)

Table 14 North America Bioprocess Validation Market Value, By Process, 2022-2031 (USD Million)

Table 15 North America Bioprocess Validation Market Value, By End-User, 2022-2031 (USD Million)

Table 16 North America Bioprocess Validation Market Value, By Country, 2022-2031 (USD Million)

Table 17 South America Bioprocess Validation Market Value, By Test Type, 2022-2031 (USD Million)

Table 18 South America Bioprocess Validation Market Value, By Process, 2022-2031 (USD Million)

Table 19 South America Bioprocess Validation Market Value, By End-User, 2022-2031 (USD Million)

Table 20 South America Bioprocess Validation Market Value, By Country, 2022-2031 (USD Million)

Table 21 Europe Bioprocess Validation Market Value, By Test Type, 2022-2031 (USD Million)

Table 22 Europe Bioprocess Validation Market Value, By Process, 2022-2031 (USD Million)

Table 23 Europe Bioprocess Validation Market Value, By End-User, 2022-2031 (USD Million)

Table 24 Europe Bioprocess Validation Market Value, By Country, 2022-2031 (USD Million)

Table 25 Asia-Pacific Bioprocess Validation Market Value, By Test Type, 2022-2031 (USD Million)

Table 26 Asia-Pacific Bioprocess Validation Market Value, By Process, 2022-2031 (USD Million)

Table 27 Asia-Pacific Bioprocess Validation Market Value, By End-User, 2022-2031 (USD Million)

Table 28 Asia-Pacific Bioprocess Validation Market Value, By Country, 2022-2031 (USD Million)

Table 29 Middle East & Africa Bioprocess Validation Market Value, By Test Type, 2022-2031 (USD Million)

Table 30 Middle East & Africa Bioprocess Validation Market Value, By Process, 2022-2031 (USD Million)

Table 31 Middle East & Africa Bioprocess Validation Market Value, By End-User, 2022-2031 (USD Million)

Table 32 Cobetter Filtration Equipments Co., Ltd.: Overview

Table 33 Cobetter Filtration Equipments Co., Ltd.: Product Portfolio

Table 34 Cobetter Filtration Equipments Co., Ltd.: Key Developments

Table 35 SGS S.A.: Overview

Table 36 SGS S.A.: Product Portfolio

Table 37 SGS S.A.: Key Developments

Table 38 DOC S.r.l.: Overview

Table 39 DOC S.r.l.: Product Portfolio

Table 40 DOC S.r.l.: Key Developments

Table 41 Thermo Fisher Scientific: Overview

Table 42 Thermo Fisher Scientific: Product Portfolio

Table 43 Thermo Fisher Scientific: Key Developments

Table 44 Toxikon Corporation: Overview

Table 45 Toxikon Corporation: Product Portfolio

Table 46 Toxikon Corporation: Key Developments

Table 47 Sartorius Stedim Biotech: Overview

Table 48 Sartorius Stedim Biotech: Product Portfolio

Table 49 Sartorius Stedim Biotech: Key Developments

Table 50 Eurofins Scientific: Overview

Table 51 Eurofins Scientific: Product Portfolio

Table 52 Eurofins Scientific: Key Developments

Table 53 all Corporation: Overview

Table 54 all Corporation: Product Portfolio

Table 55 all Corporation: Key Developments

Table 56 MEISSNER FILTRATION PRODUCTS, INC.: Overview

Table 57 MEISSNER FILTRATION PRODUCTS, INC.: Product Portfolio

Table 58 MEISSNER FILTRATION PRODUCTS, INC.: Key Developments

Table 59 Merck KGaA: Overview

Table 60 Merck KGaA: Product Portfolio

Table 61 Merck KGaA: Key Developments

그림 목록 (Figures)

List of Figures

Figure 01 Global Bioprocess Validation Market Share, By Test Type, 2022 & 2031 (%)

Figure 02 Global Bioprocess Validation Market Share, By Process, 2022 & 2031 (%)

Figure 03 Global Bioprocess Validation Market Share, By End-User, 2022 & 2031 (%)

Figure 04 Global Bioprocess Validation Market Share, By Region, 2022 & 2031 (%)

Figure 05 Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 06 Global Bioprocess Validation Market Y-o-Y Growth, By Test Type, 2022-2031 (%)

Figure 07 Extractables/Leachables Testing Services: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 08 Microbiological Testing Services: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 09 Integrity Testing Services: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 10 Physiochemical Testing Services: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 11 Compatibility Testing Services: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 12 Others: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 13 Global Bioprocess Validation Market Y-o-Y Growth, By Process, 2022-2031 (%)

Figure 14 Media containers and bags: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 15 Freezing and thawing process bags: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 16 Filter elements: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 17 Others: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 18 Global Bioprocess Validation Market Y-o-Y Growth, By End-User, 2022-2031 (%)

Figure 19 Pharmaceutical Companies: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 20 Biotechnology Companies: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 21 Others: Global Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 22 Global Bioprocess Validation Market Y-o-Y Growth, By 0, 2022-2031 (%)

Figure 23 Global Bioprocess Validation Market Y-o-Y Growth, By 0, 2022-2031 (%)

Figure 24 Global Bioprocess Validation Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 25 North America Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 26 North America Bioprocess Validation Market Share, By Test Type, 2022 & 2031 (%)

Figure 27 North America Bioprocess Validation Market Share, By Process, 2022 & 2031 (%)

Figure 28 North America Bioprocess Validation Market Share, By End-User, 2022 & 2031 (%)

Figure 29 North America Bioprocess Validation Market Share, By Country, 2022 & 2031 (%)

Figure 30 South America Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 31 South America Bioprocess Validation Market Share, By Test Type, 2022 & 2031 (%)

Figure 33 South America Bioprocess Validation Market Share, By Process, 2022 & 2031 (%)

Figure 34 South America Bioprocess Validation Market Share, By End-User, 2022 & 2031 (%)

Figure 35 South America Bioprocess Validation Market Share, By Country, 2022 & 2031 (%)

Figure 36 Europe Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 37 Europe Bioprocess Validation Market Share, By Test Type, 2022 & 2031 (%)

Figure 38 Europe Bioprocess Validation Market Share, By Process, 2022 & 2031 (%)

Figure 39 Europe Bioprocess Validation Market Share, By End-User, 2022 & 2031 (%)

Figure 40 Europe Bioprocess Validation Market Share, By Country, 2022 & 2031 (%)

Figure 41 Asia-Pacific Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 42 Asia-Pacific Bioprocess Validation Market Share, By Test Type, 2022 & 2031 (%)

Figure 43 Asia-Pacific Bioprocess Validation Market Share, By Process, 2022 & 2031 (%)

Figure 44 Asia-Pacific Bioprocess Validation Market Share, By End-User, 2022 & 2031 (%)

Figure 45 Asia-Pacific Bioprocess Validation Market Share, By Country, 2022 & 2031 (%)

Figure 46 Middle East & Africa Bioprocess Validation Market Value, 2022-2031 (USD Million)

Figure 47 Middle East & Africa Bioprocess Validation Market Share, By Test Type, 2022 & 2031 (%)

Figure 48 Middle East & Africa Bioprocess Validation Market Share, By Process, 2022 & 2031 (%)

Figure 49 Middle East & Africa Bioprocess Validation Market Share, By End-User, 2022 & 2031 (%)

Figure 50 Cobetter Filtration Equipments Co., Ltd.: Financials

Figure 51 SGS S.A.: Financials

Figure 52 DOC S.r.l.: Financials

Figure 53 Thermo Fisher Scientific: Financials

Figure 54 Toxikon Corporation: Financials

Figure 55 Sartorius Stedim Biotech: Financials

Figure 56 Eurofins Scientific: Financials

Figure 57 all Corporation: Financials

Figure 58 MEISSNER FILTRATION PRODUCTS, INC.: Financials

Figure 59 Merck KGaA: Financials